MAO
Sigaling Pathway Map
Research Area
- Inhibitory Selectivity
- Solubility
| Catalog No. | Product Name | Solubility(25°C) | ||
|---|---|---|---|---|
| Water | DMSO | Alcohol | ||
| S1472 | Safinamide Mesylate | 80 mg/mL | 80 mg/mL | 13 mg/mL |
| S2102 | Rasagiline Mesylate | 53 mg/mL | 53 mg/mL | 53 mg/mL |
| S4246 | Tranylcypromine (2-PCPA) HCl | 33 mg/mL | 33 mg/mL | 33 mg/mL |
| S3212 | Moclobemide (Ro 111163) | <1 mg/mL | 53 mg/mL | 10 mg/mL |
| S4717 | Isatin | <1 mg/mL | 29 mg/mL | 10 mg/mL |
| S2302 | Glycyrrhizin (Glycyrrhizic Acid) | 20 mg/mL | 100 mg/mL | 100 mg/mL |
| S2339 | Paeonol | <1 mg/mL | 33 mg/mL | 33 mg/mL |
Isoform-specific Inhibitors
- MAO Inhibitors (8)
- New MAO Products
| Catalog No. | Information | Product Use Citations | Product Validations |
|---|---|---|---|
| S1472 |
Safinamide MesylateSafinamide Mesylate is mesylate salt of Safinamide, selectively and reversibly inhibits MAO-B with IC50 of 98 nM, exhibits 5918-fold selectivity against MAO-A. Phase 3. |
||
| S2102 |
Rasagiline MesylateRasagiline Mesylate is a new MAO-B inhibitor for the treatment of idiopathic Parkinson's disease. |
||
| S4246 |
Tranylcypromine (2-PCPA) HClTranylcypromine is a monoamine oxidase inhibitor, which inhibits CYP2A6 with Ki of 0.08 μM and 0.2 μM in cDNA-expressing microsomes and Human Liver Microsomes, respectively. |
||
| S3212 |
Moclobemide (Ro 111163)Moclobemide is a MAO-A (5-HT) inhibitor with IC50 of 6.1 μM. |
Inguinal adipose stromal cells were differentiated into adipocytes, treated with various chemical inhibitors (1 μM) with or without harmine (1 μM) for 24 h, and then harvested for qPCR and western blot analysis (n = 6 wells/group). Quantitative PCR analysis of Ucp1 expression in the adipocytes treated with harmine and (a) DYRK1A inhibitor, (b) MAO-A inhibitor. Data represent mean ± SEM. *p < 0.05.
|
|
| S4033 |
Sennoside ASennoside A, a kind of irritant laxative isolated from rhei rhizome, causes purgative actions in the intestine. |
||
| S4717New |
IsatinIsatin is an endogenous MAO inhibitor and more active against MAO-B than MAO-A |
||
| S2302 |
Glycyrrhizin (Glycyrrhizic Acid)Glycyrrhizin (Glycyrrhizic Acid) is a direct HMGB1(high mobility group box 1) inhibitor that inhibits HMGB1-dependent inflammatory molecule expression and oxidative stress; modulates P38 and P-JNK but not p-ERK signalling; Also inhibits 11 beta-hydroxysteroid dehydrogenase and monoamine oxidase (MAO). |
||
| S2339 |
PaeonolPaeonol (Peonol), a phenolic compound extracted from Chinese herbs Paeonia suffruticosa (moutan cortex) and Cynanchum paniculatum, inhibits MAO with an IC50 of about 50 μM. |
| Catalog No. | Information | Product Use Citations | Product Validations |
|---|---|---|---|
| S1472 |
Safinamide MesylateSafinamide Mesylate is mesylate salt of Safinamide, selectively and reversibly inhibits MAO-B with IC50 of 98 nM, exhibits 5918-fold selectivity against MAO-A. Phase 3. |
||
| S2102 |
Rasagiline MesylateRasagiline Mesylate is a new MAO-B inhibitor for the treatment of idiopathic Parkinson's disease. |
||
| S4246 |
Tranylcypromine (2-PCPA) HClTranylcypromine is a monoamine oxidase inhibitor, which inhibits CYP2A6 with Ki of 0.08 μM and 0.2 μM in cDNA-expressing microsomes and Human Liver Microsomes, respectively. |
||
| S3212 |
Moclobemide (Ro 111163)Moclobemide is a MAO-A (5-HT) inhibitor with IC50 of 6.1 μM. |
Inguinal adipose stromal cells were differentiated into adipocytes, treated with various chemical inhibitors (1 μM) with or without harmine (1 μM) for 24 h, and then harvested for qPCR and western blot analysis (n = 6 wells/group). Quantitative PCR analysis of Ucp1 expression in the adipocytes treated with harmine and (a) DYRK1A inhibitor, (b) MAO-A inhibitor. Data represent mean ± SEM. *p < 0.05.
|
|
| S4033 |
Sennoside ASennoside A, a kind of irritant laxative isolated from rhei rhizome, causes purgative actions in the intestine. |
||
| S4717New |
IsatinIsatin is an endogenous MAO inhibitor and more active against MAO-B than MAO-A |
||
| S2302 |
Glycyrrhizin (Glycyrrhizic Acid)Glycyrrhizin (Glycyrrhizic Acid) is a direct HMGB1(high mobility group box 1) inhibitor that inhibits HMGB1-dependent inflammatory molecule expression and oxidative stress; modulates P38 and P-JNK but not p-ERK signalling; Also inhibits 11 beta-hydroxysteroid dehydrogenase and monoamine oxidase (MAO). |
||
| S2339 |
PaeonolPaeonol (Peonol), a phenolic compound extracted from Chinese herbs Paeonia suffruticosa (moutan cortex) and Cynanchum paniculatum, inhibits MAO with an IC50 of about 50 μM. |
